ENS 56619: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
Line 20: | Line 20: | ||
On July 11, 2023, at 1700 EDT, an intravascular brachytherapy treatment was delivered to the wrong treatment site. The original dose of 23 Gy was intended for a different part of the vasculature system. The brachytherapy device made by Best Vascular is a Beta-Catch (model # 5ICW-2) containing 3.62 GBq of Sr/Y-90. Physicians expect that there will be no permanent damage to any of the patient's organs. | On July 11, 2023, at 1700 EDT, an intravascular brachytherapy treatment was delivered to the wrong treatment site. The original dose of 23 Gy was intended for a different part of the vasculature system. The brachytherapy device made by Best Vascular is a Beta-Catch (model # 5ICW-2) containing 3.62 GBq of Sr/Y-90. Physicians expect that there will be no permanent damage to any of the patient's organs. | ||
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient. | A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient. | ||
| URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2023/ | | URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2023/20230720en.html#en56619 | ||
}} | }} | ||
{{ENS-Nav}} | {{ENS-Nav}} |
Latest revision as of 06:30, 20 July 2023
Where | |
---|---|
Henry Ford Hospital Detroit, Michigan (NRC Region 3) | |
License number: | 21-04109-16 |
Organization: | Henry Ford Hospital |
Reporting | |
10 CFR 35.3045(a)(2) | |
Time - Person (Reporting Time:+15.22 h0.634 days <br />0.0906 weeks <br />0.0208 months <br />) | |
Opened: | Alan Jackson 12:13 Jul 12, 2023 |
NRC Officer: | Ian Howard |
Last Updated: | Jul 12, 2023 |
56619 - NRC Website | |